Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...
The FDA has approved Zevra Therapeutics' Miplyffa (arimoclomol) as the first treatment for neurological symptoms of ...
McEwan and James have now taken advantage of TRIM21’s cluster activation by turning it against another protein with a ...
HealthDay on MSN3d
SGLT2i Use Linked to Lower Risk for Neurodegenerative Disease in T2DMFor patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced risks for ...
ABOVE: Protein misfolding plays an important role in many neurodegenerative disorders. © istock.com, Eoneren. W hen Julie ...
Study connects the swip-10 gene in roundworms to copper metabolism and neurodegeneration. Loss of swip-10 impairs copper ...
Research enhances our comprehension of neurodegenerative diseases associated with protein aggregation. A recent study ...
In Alzheimer's disease and primary 4-repeat tauopathies, large pathological aggregates of the tau protein are found in the brain. For decades, it has been possible to detect tau proteins for Alzheimer ...
A new study has found a possible link between supine sleep — or sleeping on one's back — and neurodegenerative conditions ...
MADRID — Patients with type 2 diabetes treated with sodium-glucose cotransporter 2 inhibitors (SGLT2is) show significant ...
Cambridge Independent on MSN3d
Promising ‘Trojan horse’ potential therapies against Alzheimer’s and other diseases developed by Cambridge scientistsThe TRIM21 therapies have been shown to remove toxic tau proteins and reduce symptoms of neurodegeneration in mice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback